"Immunologic Surveillance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The theory that T-cells monitor cell surfaces and detect structural changes in the plasma membrane and/or surface antigens of virally or neoplastically transformed cells.
| Descriptor ID |
D007157
|
| MeSH Number(s) |
G12.450.050.400.412 G12.525
|
| Concept/Terms |
Immunologic Surveillance- Immunologic Surveillance
- Immunological Surveillance
- Immunological Surveillances
- Surveillance, Immunological
- Surveillances, Immunological
- Surveillance, Immunologic
- Immunologic Surveillances
- Surveillances, Immunologic
|
Below are MeSH descriptors whose meaning is more general than "Immunologic Surveillance".
Below are MeSH descriptors whose meaning is more specific than "Immunologic Surveillance".
This graph shows the total number of publications written about "Immunologic Surveillance" by people in this website by year, and whether "Immunologic Surveillance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunologic Surveillance" by people in Profiles.
-
Dillon A, Lo DD. M Cells: Intelligent Engineering of Mucosal Immune Surveillance. Front Immunol. 2019; 10:1499.
-
Renrick AN, Dunbar ZT, Shanker A. Update?on the current revolution in cancer immunotherapy. Immunotherapy. 2019 01; 11(1):15-20.
-
Lo DD. Vigilance or Subversion? Constitutive and Inducible M Cells in Mucosal Tissues. Trends Immunol. 2018 03; 39(3):185-195.
-
Sopper S, Mustjoki S, White D, Hughes T, Valent P, Burchert A, Gjertsen BT, Gastl G, Baldauf M, Trajanoski Z, Giles F, Hochhaus A, Ernst T, Schenk T, Janssen JJ, Ossenkoppele GJ, Porkka K, Wolf D. Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia. J Clin Oncol. 2017 Jan 10; 35(2):175-184.
-
Huang Y, Lin L, Shanker A, Malhotra A, Yang L, Dikov MM, Carbone DP. Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth. Cancer Res. 2011 Oct 01; 71(19):6122-31.
-
Lo D. Exploiting immune surveillance mechanisms in mucosal vaccine development. Expert Opin Biol Ther. 2004 Mar; 4(3):397-406.
-
Nguyen LT, Elford AR, Murakami K, Garza KM, Schoenberger SP, Odermatt B, Speiser DE, Ohashi PS. Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance. J Exp Med. 2002 Feb 18; 195(4):423-35.